Succinamide

Succinamide

SCHEMBL6270786

CC(C)(CO)C(N)=O.NC(=O)CCC(N)=O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
ALOX15 P16050 2/20 0.35
BLM P54132 2/20 0.35
PMP22 Q01453 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GMNN O75496 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GLA P06280 1/20 0.35
POLB P06746 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
THPO P40225 1/20 0.35
RECQL P46063 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1327762 0.89
Hydrochloric Acid SCHEMBL11595789 0.87
SCHEMBL3293803 0.79 LMNA (0.38) TP53CYP1A2CYP3A4CYP2C19ALOX15
Hydrochloric Acid SCHEMBL6214815 0.77 LMNA (0.36) TP53CYP1A2CYP3A4CYP2C19ALOX15
SCHEMBL232206 0.77 KDM4E (0.36) TP53CYP1A2CYP3A4CYP2C19ALOX15
Fumaric Acid SCHEMBL4347340 0.76 TSHR (0.41) TP53CYP1A2CYP2C19ALOX15BLM
SCHEMBL22662460 0.75 KDM4E (0.30) KDM4ETDP1
Hydrochloric Acid SCHEMBL561987 0.75 KDM4E (0.35) TP53CYP1A2CYP3A4CYP2C19ALOX15
Hydrochloric Acid SCHEMBL691540 0.75 KDM4E (0.35) TP53CYP1A2CYP3A4CYP2C19ALOX15
SCHEMBL154713 0.75 SOAT1 (0.39) TP53CYP1A2CYP3A4CYP2C19ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005448-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS Du Pont Pharmaceuticals Company (US) 2000-06-07 EP claimed
WO-1999009000-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS DU PONT PHARMACEUTICALS COMPANY (US) 1999-02-25 WO claimed
WO-2005108949-A2 METHODS, COMPOSITIONS AND COMPOUND ASSAYS FOR INHIBITING AMYLOID-BETA PROTEIN PRODUCTION GALAPAGOS N.V. (BE) 2005-11-17 WO disclosed
EP-1005448-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS Du Pont Pharmaceuticals Company (US) 2000-06-07 EP disclosed
WO-1999009000-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS DU PONT PHARMACEUTICALS COMPANY (US) 1999-02-25 WO disclosed